Reference health

RETRACTED: Echinacoside improves diabetic liver injury by regulating the AMPK/SIRT1 signaling pathway in db/db mice

https://doi.org/10.1016/j.lfs.2021.119237
CiteStamped reference-health badge
31/31 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 31 checked references that resolve
resolves10.1056/NEJMra1503519
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
resolves10.1056/NEJMra011775
Nonalcoholic Fatty Liver Disease
resolves10.4254/wjh.v9.i16.715
Non-alcoholic fatty liver disease: An expanded review
resolves10.1002/hep.1840360609
NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States
resolves10.1038/nature07813
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
resolves10.12659/MSM.897207
Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1
resolves10.1002/0471141755.ph0561s58
Overview of Animal Models of Obesity
resolves10.1016/j.diabres.2013.11.002
Global estimates of diabetes prevalence for 2013 and projections for 2035
resolves10.1136/bmj.m997
Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study
resolves10.1056/NEJMoa0908292
Prevalence of Diabetes among Men and Women in China
resolves10.1136/flgastro-2019-101235
NAFLD: a multisystem disease that requires a multidisciplinary approach
resolves10.1016/j.jhep.2019.06.021
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
resolves10.1016/j.mgene.2020.100714
Association of ABCA1 (C69T) gene polymorphism with dyslipidemia and type 2 diabetes among the Egyptian population
resolves10.1016/j.metabol.2015.12.012
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
resolves10.1142/S0192415X12500838
<i>Cistanche deserticola</i> Y. C. Ma, "Desert Ginseng": A Review
resolves10.1016/j.jep.2013.09.027
Anti-hyperglycemic and hypolipidemic effects of Cistanche tubulosa in type 2 diabetic db/db mice
resolves10.1016/j.molcel.2017.05.032
AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance
resolves10.1016/j.fct.2018.09.079
Natural activators of adenosine 5′-monophosphate (AMP)-activated protein kinase (AMPK) and their pharmacological activities
resolves10.1016/j.pharmthera.2014.02.008
Past strategies and future directions for identifying AMP-activated protein kinase (AMPK) modulators
resolves10.1016/j.tem.2017.05.004
AMPK as a Therapeutic Target for Treating Metabolic Diseases
resolves10.1097/MOL.0b013e328328d0a4
PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
resolves10.4161/cc.7.23.7164
Comparing and contrasting the roles of AMPK and SIRT1 in metabolic tissues
resolves10.3748/wjg.v22.i46.10084
Sirtuins and nonalcoholic fatty liver disease
resolves10.1016/j.orcp.2017.10.004
Reduced gene expression of sirtuins and active AMPK levels in children and adolescents with obesity and insulin resistance
resolves10.1007/s12020-014-0465-x
Plasma levels of SIRT1 associate with non-alcoholic fatty liver disease in obese patients
resolves10.1016/j.cmet.2012.04.003
SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function
resolves10.1016/j.cmet.2009.02.006
Hepatocyte-Specific Deletion of SIRT1 Alters Fatty Acid Metabolism and Results in Hepatic Steatosis and Inflammation
resolves10.1152/ajprenal.00263.2017
PGC1α in the kidney
resolves10.1016/j.biochi.2016.12.019
The role and regulation of the peroxisome proliferator activated receptor alpha in human liver
resolves10.1016/j.jhep.2014.10.039
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
resolves10.1002/path.4760
Dysregulation of hepatic <scp>cAMP</scp> levels via altered Pde4b expression plays a critical role in alcohol‐induced steatosis
The 3 references without a DOI — listed, not checked
no DOI — not checkedThe challenge of traditional chinese medicines for allopathic practitioners
no DOI — not checked10.1016/j.lfs.2021.119237_bb0080
no DOI — not checkedSirt1 disruption in human fetal hepatocytes leads to increased accumulation of glucose and lipids
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/j.lfs.2021.119237"><img src="https://citestamp.com/citestamped/10.1016/j.lfs.2021.119237/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/j.lfs.2021.119237/badge.svg)](https://citestamp.com/citestamped/10.1016/j.lfs.2021.119237)